Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Pupillary dilatation with ketorolac trometamol (Acular) conjunctly to prevent miosis in femtolaser-assisted cataract surgery (FLACS)

Search Title by author or title

Session Details

Session Title: Presented Poster Session: FLACS

Session Date/Time: Monday 12/09/2016 | 15:00-16:30

Paper Time: 15:40

Venue: Poster Village: Pod 4

First Author: : C.Chen TAIWAN

Co Author(s): :    C. Wu              

Abstract Details

Purpose:

Pupillary constriction is an annoying problem in FLACS. It maybe due to femtolaser energy delivered or by prostaglandins released. We try to use ketorolac trometamol (Acular) to decrease the effect of prostaglandins in the eye, and to avoid miosis in FLACS.

Setting:

One hundred and twenty patients treated with LensAR FLACS system in the operating room at Taipei Municipal Wan-Fang Hospital.

Methods:

Sixty-seven eyes underwent 1% tropicamide, 0.5% phenylephrine for pre-operative pupillary dilatation; compared with fifty-five patients conjunctly used ketorolac trometamol ( Acular) for pupil dilatation. The diameter of pupil was recorded by surgical caliper and LensAR on the three time-points: the time of beginning FLACS, the time on LensAR ducking was ready, and the time while the LensAR was done, and began phaco surgery. All the data of patients was keyed in the EXCEL file, and be analyzed by SPSS. Descriptive methods of frequency and independent t-test were used.

Results:

In the no Acular-usage group (control group), 25.4% patients had pupillary constriction as pupil diameter below 5.5 mm after laser application. Compared with 12.1% in Acular-usage group (study group). The mean of post-laser pupil (area) / pre-laser pupil (area) ratio was 69.3% in no Acular-usage group, compared with 84.8% in Acular -usage group; with significant difference ( p=0.04).

Conclusions:

Ketorolac trometamol ( Acular) can be used conjunctly for pupillary dilatation with routine mydriatic drugs, especially in the FLACS to avoid intraoperative miosis.

Financial Disclosure:

NONE

Back to previous